MSP AT CPHI MILAN 2026

Milan became the epicenter of global healthcare innovation this week as CPHI 2026 took over Fiera Milano from October 6 to 8. Drawing an unprecedented crowd of over 62,000 industry pioneers from 166 countries, the event underscored a transformative era in medicine where cutting-edge biopharma, digital technology, and regulatory evolution intersect.

For Mykhailyuk, Sorokolat & Partners, CPHI Milan 2026 provided an invaluable venue to directly engage with industry leaders navigating the complexities of entering emerging markets.

As global pharmaceutical pipelines increasingly rely on proprietary technologies and regional growth, MSP’s team offered hands-on expertise in Intellectual Property strategy and Regulatory Affairs across Eastern Europe and Central Asia. From advising biopharma startups on early-stage patent filings to assisting multinational manufacturers with regulatory registrations, MSP ensured that clients' most valuable assets remain fully protected.

Our team’s presence at CPHI Milan 2026 reinforces MSP’s commitment to bridging international markets and safeguarding the intellectual achievements driving tomorrow’s medicine.